Episode Details
Back to Episodes
EP366: LDL is a Remnant or a Waste Product of Lipid Metabolism
Description
Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.
Podcast Summary
Dr. Oreck Bishop hosts this educational podcast and videocast, where he explains the complex mechanisms of lipid and lipoprotein particle movement throughout the body. The episode focuses on clarifying how these particles primarily function as energy delivery systems, and he also addresses a listener question about AV nodal ablation for atrial fibrillation treatment.
Key Takeaways:
-
Lipoprotein particles' main role is to deliver energy sources (triglycerides) to tissues throughout the body, not primarily to transport cholesterol.
-
Dietary fats are absorbed in the gut, bundled into chylomicrons, and transported via the lymph system, where lipoprotein lipase extracts triglycerides for tissue use.
-
LDL cholesterol is a remnant particle created after triglycerides are removed from lipoproteins; it's not directly produced by the liver but rather taken up from circulation.
-
The liver produces VLDL (very low-density lipoprotein) as an energy source to tissues, which undergoes the same process as chylomicrons, leaving LDL remnants in the bloodstream.
-
Statins and bempedoic acid work by blocking HMG-CoA reductase, reducing cholesterol production in cells, which triggers cells to absorb more LDL cholesterol from the bloodstream.
-
Blood test measurements of LDL cholesterol reflect particle cholesterol in circulation only, not the total cholesterol content within individual cells throughout the body.
-
Every tissue in the body has LDL receptors that allow cells to take up cholesterol for synthesis purposes such as repair and hormone formation.
-
AV nodal ablation is an important treatment option for rate control in atrial fibrillation when other treatments have failed, typically accompanied by pacemaker implantation.